IREN
IREN Limited
There isn't enough reported data to score IREN yet.
SRCE
1st Source Corporation
SRCE's fundamentals are strong: its operating margin rose 5 points to 50% and revenue grew 9.9%. At 12x earnings, it's trading above its usual 11x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
SRCE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
SRCE's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like SRCE.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
SRCE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $70.88 | -20% |
| Fair | 11x | $78.05 | -12% |
| Expensive | 12x | $90.07 | +2.1% |
| Current | 12x | $88.25 | — |
| Forward | 12x | $88.25 | — |
Historical ranges are pointers, not guarantees.
SRCE's PE is in its expensive range at 12.1x. If earnings grow as analysts expect, today's price would be 11.6x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SRCE Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
SRCE has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
SRCE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.59 | +4.2% |
| Q3 2026 | $7.28 | +21% |
| Q2 2026 | $6.96 | +22% |
| Q1 2026 | $6.52 | +15% |
| Q4 2025 | $6.41 | +20% |
| Q3 2025 | $6.01 | +14% |
| Q2 2025 | $5.71 | +11% |
| Q1 2025 | $5.69 | +14% |
| Q4 2024 | $5.36 | +6.6% |
SRCE has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
SRCE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $120.3M | +8.7% |
| Q2 2026 | $118.2M | +9.2% |
| Q1 2026 | $113.1M | +8.7% |
| Q4 2025 | $110.8M | +13% |
| Q3 2025 | $110.7M | +13% |
| Q2 2025 | $108.2M | +11% |
| Q1 2025 | $104M | +11% |
| Q4 2024 | $97.8M | +7% |
SRCE's revenue has grown year over year for 11 quarters in a row: $120M last quarter, up 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 53% | +3.7 points |
| Q2 2026 | 52% | +7.7 points |
| Q1 2026 | 45% | -0.5 points |
| Q4 2025 | 48% | +7.4 points |
| Q3 2025 | 50% | +3.3 points |
| Q2 2025 | 44% | -4.6 points |
| Q1 2025 | 46% | +5.6 points |
| Q4 2024 | 41% | +1 points |
SRCE has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
SRCE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $69.1M | +46% |
| Q2 2026 | $49.3M | +15% |
| Q1 2026 | $58.1M | -16% |
| Q4 2025 | $53.5M | +98% |
| Q3 2025 | $47.3M | -29% |
| Q2 2025 | $43M | -7.3% |
| Q1 2025 | $69.3M | +67% |
| Q4 2024 | $27M | -34% |
SRCE has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
SRCE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +9.9K shares |
| 1 year | -1.6% | -389K shares |
| 3 years | -2.3% | -577K shares |
| 5 years | -3.4% | -837K shares |
| Available history | -5.9% | -1.5M shares |
SRCE has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $23.4M |
| Q4 2025 | $4.2M |
| Q3 2025 | $6.4M |
| Q2 2025 | $2.8M |
| Q1 2025 | $455,000 |
| Q4 2024 | $178,000 |
SRCE spent $28M buying back its own shares over the past year, up 180% from the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
SRCE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Very low |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | 1.7x | Healthy |
SRCE's net debt is about a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like SRCE.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
SRCE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 55.9 | Neutral |
SRCE's weekly RSI is 64 (neutral) and its Stochastic is 56 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
SRCE PE vs Financial Services Sector
| Metric | SRCE | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.9% below |
| PE % | 79 | 63 | 16 pts above |
SRCE is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
SRCE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $86.6 | 1.9% above |
| 20 week MA | $86.2 | 2.4% above |
| 50 week MA | $76.6 | 15% above |
| 100 week MA | $68.7 | 28% above |
| 200 week MA | $59.7 | 48% above |
SRCE has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
SRCE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.0 | $39.9 | -23% |
| 2021 | $39.9 | $48.4 | +21% |
| 2022 | $48.4 | $54.3 | +12% |
| 2023 | $54.3 | $55.0 | +1.3% |
| 2024 | $55.0 | $58.6 | +6.7% |
| 2025 | $58.6 | $64.0 | +9.1% |
| 2026 YTD | $64.0 | $88.3 | +38% |
SRCE has the edge over IREN on returns for 2026, with the stronger performance.